Skip to search formSkip to main contentSkip to account menu

Saquinavir:MCnc:Pt:Ser/Plas:Qn

Known as: Saquinavir:Mass Concentration:Point in time:Serum/Plasma:Quantitative, Saquinavir [Mass/volume] in Serum or Plasma, Saquinavir:MCnc:Pt:Sor/Plas:Qn 
National Institutes of Health

Related topics

Related topics

4 relations
PlasSaquinavirSerumUnit of Mass Concentration

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Validation of the international pharmacopoeia method for the determination of related substances in saquinavir and saquinavir mesilate
2005
2005
Comparison and improvement of liquid chromatographic methods for the determination of related substances in saquinavir and saquinavir mesilate
2003
2003
The Preparedness of national secondary school teachers in Nairobi Province to implement HIV/AIDS Education curriculum
xv 
Review
2000
Review
2000
Saquinavir soft-gel capsule: an updated review of its use in the management of HIV infection.
UNLABELLED Saquinavir is a potent and highly selective HIV protease inhibitor. Initially formulated as a hard-gel capsule (HGC… 
1998
1998
The great salvage therapy drug juggle.
Most patients on protease inhibitors who plateau at viral loads within quantifiable levels must switch to an alternative or… 
1997
1997
Update on antivirals.
Recent studies are indicating that the standard version of saquinavir is not an appropriate anti-HIV regimen protease inhibitor… 
1995
1995
A kinder, gentler ddC... for $7,200 a year.
Hoffman-LaRoche's saquinavir (Invirase) is the first protease inhibitor to be granted approval by the Food and Drug… 
1994
1994
Characterisation of HIV drug sensitivity during antiretroviral treatment with a protease inhibitor (Ro 31???8959 - saquinavir) alone or in combination with zidovudine